Test Price
2,800 AED✅ Home Collection Available
SUCLA2 Gene Mitochondrial DNA Depletion Syndrome Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Diagnostic Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified processing and NGS technology with full gene coverage.
- Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM across all UAE emirates.
- Clinical Guidance: Post-test telephonic interpretation by a DHA-licensed Consultant Medical Geneticist.
- Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SUCLA2 gene NGS test detects pathogenic variants associated with mitochondrial DNA depletion syndrome type 5 (MTDPS5), a severe encephalomyopathic disorder presenting in infancy with hypotonia, developmental regression, and methylmalonic aciduria. This test confirms diagnosis and guides genetic counseling for at-risk families.
| Feature | Our Test (Premium) | Conventional Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) with full gene coverage & variant validation | Sanger sequencing of a single exon or targeted panel |
| Diagnostic Precision | 99.9% Analytical Sensitivity, including deep intronic & CNV detection | ~95% sensitivity; may miss large deletions or deep intronic mutations |
| Turnaround Time | 3 to 4 Weeks (with pre‑test genetic counselling included) | 4–6 Weeks, often without genetic counselling support |
| Sample Collection | VIP Mobile Phlebotomy; Blood, Extracted DNA, or FTA card | In‑clinic venipuncture only |
| Post‑Test Guidance | Telephonic interpretation by DHA‑licensed Consultant Medical Geneticist | Report only; no clinical consultation |
Physician Insight & Safety Protocols
“A positive SUCLA2 result must be correlated with the child’s neurological and metabolic phenotype; a negative result does not exclude all mitochondrial disorders. Families should undergo post‑test genetic counseling to understand recurrence risks and available supportive therapies. This test is performed under the supervision of a consultant medical geneticist.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Medication Advisory
Do not discontinue any prescribed anti‑epileptic, metabolic, or dietary management medications prior to or after this test without explicit instruction from your treating physician.
Exclusion Criteria & Emergency Red Flags
- Active acute infection or septic shock – postpone home collection.
- Severe coagulopathy or ongoing anticoagulant therapy not disclosed during booking.
- Patients under 18 years without guardian‑signed informed consent (minors require documentation compliant with Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Emergency symptoms suggesting metabolic crisis (e.g., intractable vomiting, lethargy, seizures) warrant immediate hospital attendance, not home sample collection.
Patient FAQ & Clinical Guidance
1. What does the SUCLA2 genetic test detect, and when is it recommended?
Our NGS‑based SUCLA2 gene test detects pathogenic variants causing mitochondrial DNA depletion syndrome type 5, recommended for infants or children with hypotonia, developmental delay, and elevated methylmalonic acid.
2. How is the sample collected, and is home service available across the UAE?
A trained phlebotomist draws a small blood sample or collects a single drop on an FTA card during a pre‑scheduled home visit, available in all emirates from 8 AM to 11 PM with full cold‑chain handling.
3. Will my health insurance cover the 2800 AED cost, and how do I confirm?
We provide direct billing verification to major UAE insurers; simply send your insurance card via WhatsApp to +971 54 548 8731 to confirm coverage before booking.
4. How long does it take to get results, and what does the report include?
Turnaround time is 3 to 4 weeks. The report includes variant interpretation, classification per ACMG guidelines, and a telephonic explanation from a consultant medical geneticist.
5. Is genetic counseling provided with the test?
Yes, pre‑test counseling is included in the price, and post‑test counseling is provided by our DHA‑licensed geneticist to discuss results, recurrence risk, and family planning.
UAE Regulatory & Data Privacy Adherence
- This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical testing safety and patient consent comply with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- All processes are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
- Personal health data is encrypted and stored in compliant data centers within the UAE.
Clinical & Logistical Metadata
| Test Name | SUCLA2 Gene Mitochondrial DNA Depletion Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | E88.49 (Mitochondrial disorder, not elsewhere classified) |
| LOINC Code | 21730-8 (SUCLA2 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA Facility License: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians